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Abstract- Introduction: This study investigated the levels of inflammatory biomarkers in healthy children 
and those diagnosed with type 1 diabetes (T1DM), some of whom were affected by endothelial 
dysfunction (ED), characterized by increased inflammation and reduced vasodilatation. 
Methods: Thirty-one T1DM children showing no symptoms of vascular diseases and diagnosed by 
ultrasound techniques as ED-positive (T1DM-ED) or negative (T1DM), and 58 sex-age-matched healthy 
children were investigated for circulating levels of E-selectin, s-ICAM and s-VCAM, MMP-9, high-sensitivity 
C-reactive protein (hsCRP), and IL-6. 
Results: No differences were observed in s-ICAM, MMP-9, and IL-6 levels between case and control 
groups. Significantly higher levels of s-VCAM (p= 0.0001) were found in the T1DM (1359.1 ± 273 ng/mL) 
and T1DM-ED (1358.2 ± 112 ng/mL) groups; (control - 828.5 ± 212 ng/mL). Higher levels of E-selectin  
(p = 0.001) were found in the T1DM-ED group (331.2 ± 77 ng/mL); (control - 222.2 ± 74 ng/mL). The 
values of hsCRP were higher (p = 0.002) in the T1DM-ED group (0.36 ± 0.2 mg/L) relative to control  
(0.15 ± 0.1 mg/L) and T1DM (0.19 ± 0.2 mg/L). The results suggest that E-selectin and hsCRP can be 
useful markers of ED in children with T1DM. 
Keywords: type 1 diabetes mellitus, children, endothelial dysfunction, markers, E-selectin, hsCRP. 
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Abstract- Introduction: This study investigated the levels of 
inflammatory biomarkers in healthy children and those 
diagnosed with type 1 diabetes (T1DM), some of whom were 
affected by endothelial dysfunction (ED), characterized by 
increased inflammation and reduced vasodilatation. 
Methods: Thirty-one T1DM children showing no symptoms of 
vascular diseases and diagnosed by ultrasound techniques as 
ED-positive (T1DM-ED) or negative (T1DM), and 58 sex-age-
matched healthy children were investigated for circulating 
levels of E-selectin, s-ICAM and s-VCAM, MMP-9, high-
sensitivity C-reactive protein (hsCRP), and IL-6. 
Results: No differences were observed in s-ICAM, MMP-9, and 
IL-6 levels between case and control groups. Significantly 
higher levels of s-VCAM (p= 0.0001) were found in the T1DM 
(1359.1 ± 273 ng/mL) and T1DM-ED (1358.2 ± 112 ng/mL) 
groups; (control - 828.5 ± 212 ng/mL). Higher levels of E-
selectin (p = 0.001) were found in the T1DM-ED group (331.2 
± 77 ng/mL); (control - 222.2 ± 74 ng/mL). The values of 
hsCRP were higher (p = 0.002) in the T1DM-ED group (0.36 ± 
0.2 mg/L) relative to control (0.15 ± 0.1 mg/L) and T1DM (0.19 
± 0.2 mg/L). The results suggest that E-selectin and hsCRP 
can be useful markers of ED in children with T1DM. 
Keywords: type 1 diabetes mellitus, children, endothelial 
dysfunction, markers, E-selectin, hsCRP. 
I. Introduction 
ype 1 diabetes mellitus (T1DM) is a complex 
metabolic disorder characterized by chronic 
hyperglycemia due to a complete lack of insulin 
secretion [1]. The constant hyperglycemic state 
associated with the increase in circulating free fatty 
acids trigger molecular mechanisms that lead to a 
decrease in nitric oxide (NO) bioavailability, increased 
oxidative stress, increased expression of pro-
inflammatory and prothrombotic factors, and reduced 
vasodilatation, promoting endothelial dysfunction [2]. 
 
Author α Ѡ : Graduate Program in Medical Sciences, Faculty of 
Medicine, University of Brasilia, Brasília, DF, Brazil. 
e-mail: yannanobrega@gmail.com 
Author α: University of Brasilia Hospital, Darcy Ribeiro University 
Campus, Brasília, DF, Brazil. 
Author ρ: CMA, Department of Mathematics, College of Sciences and 
Technology, New University of Lisbon, Campus Caparica, Caparica, 
Portugal.  
Author σ Ѡ: Department of Pharmaceutical Sciences, College of Health 
Sciences, University of Brasilia, Brasília, DF, Brazil. 
Endothelial dysfunction (ED) precedes the 
cardiovascular complications that are the leading 
cause of death in diabetic patients. Nephropathy, 
retinopathy, and neuropathy are some of the most 
common microvascular complications, where as 
cardiovascular disease, peripheral arterial disease, and 
stroke are the main macrovascular complications. 
Currently, ED has gained attention as a predictor of 
T1DM-related vascular diseases [3].However, little is 
known about the early stages of vascular alterations in 
children with diabetes.  
 
 
Other important molecules involved in ED are 
matrix metalloproteinases (MMPs), endopeptidases 
that are secreted by macrophages and act in            
the degradation and remodeling of extracellular matrix 
components, such as collagen, proteoglycans, elastin, 
fibronect in, and other glycoproteins [10,11,12]. In 
diabetes, high glucose levels lead to changes in MMP 
regulation, altering the balance between the synthesis 
and degradation of matrix components [13]. MMP-9 is 
an essential molecule for vascular remodeling,         
and studies indicate that this metalloproteinase is 
involved in the formation and destabilization of 
atheromatous plaques [10,14] and in ischemic stroke 
[15]. Other studies have shown higher levels of MMP-9 
in patients with diabetic complications [16], including 
children [17]. 
Moreover, C-reactive protein, produced and 
released by hepatocytes after stimulation by 
interleukins IL-1 and IL-6, plays an important role in 
ED: it reduces eNOS messenger RNA transcription and 
NO formation, increases the release of ET-1 and IL-6, 
and induces the release of adhesion molecules and 
T 
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In recent years, several molecules are being 
considered new biomarkers of ED, such as VCAM-1 
(vascular cell adhesion molecule-1), ICAM-1 
(intercellular adhesion molecule-1), and E-selectin. 
These molecules are involved in the adhesion of 
leukocytes to the vascular wall and are associated with 
endothelial dysfunction, retinopathy, albuminuria, and 
coronary disease [4,5]. Several studies have 
suggested that these molecules are present in higher 
levels in patients with diabetes [6,7,8,9,10].
chemotactic cytokines [18]. It has previously been 
shown that CRP and IL-6 are associated with T1DM-
related cardiovascular events and microangiopathy 
[19]. 
Circulating biomarkers such as E-selectin, 
soluble ICAM and VCAM, MMP-9, CRP, and IL-6 play a 
significant role in ED. Consequently, they may contribute 
to both the early diagnosis of the inflammatory process 
involved in ED and the development of new therapeutic 
strategies [20]. The aim of this study was to investigate 
the association of these markers with the presence or 
absence of ED in children with T1DM. 
II. Material and Methods 
a) Study Participants 
 
 
 
 
 
   
 
 
Exclusion criteria for both groups were onset of 
puberty, evidence of hypertension, dyslipidemia (total 
cholesterol ≥ 200 mg/dL, HDL <45mg/dL, LDL ≥130 
mg/dL, VLDL ≥ 41mg/dL, triglycerides ≥100 mg/dL  for 
children aged up to 10 years old, or triglycerides ≥130 
mg/Dl for children older than 10), family history of 
primary dyslipidemia and premature death due to 
cardiovascular or cerebrovascular disease, presence of 
anemia (hemoglobin <11 g/L and hematocrit <33%), 
presence of acute infectious conditions or chronic 
conditions other than diabetes mellitus, and continued 
use of medications other than insulin. 
The study was carried out in accordance with 
The Code of Ethics of the World Medical Association 
(Declaration of Helsinki). Parents or legal guardians of 
the children participating in the study signed an 
informed consent form. The study was approved by the 
University of Brasilia’s College of Health Science’s (CEP-
FS) Research Ethics Committee. 
The children were divided into three groups 
according to the presence of type 1 diabetes mellitus 
and endothelial dysfunction: healthy children (control), 
Children with T1DM and no endothelial dysfunction 
(T1DM), and children with T1DM and presenting 
endothelial dysfunction (T1DM-ED).  
b) Laboratory Analysis of Biomarkers 
Serum samples were collected after 8 h of 
fasting, according to the H3-A6 standard of the Clinical 
and Laboratory Standards Institute (CLSI) [23] in serum 
separator tubes. Samples were centrifuged at 3000 rpm, 
and the serum was stored at -2°C until used for 
measuring the levels of high-sensitivity C-reactive 
protein (hs-CRP), interleukin-6 (IL-6), endothelial selectin 
(E-selectin), soluble intercellular adhesion molecule-1 
(sICAM-1), soluble vascular cell adhesion molecule-1 
(sVCAM-1), and the marker of vascular damage matrix 
metalloproteinase-9 (MMP-9). The method of 
measurement and the equipment used are summarized 
in Table 1.  
Table 1: Methods and Equipment used for Determining Serum Levels of each Marker 
Marker Equipment and Manufacturer Method 
sE-selectin 
BEST 2000 ELISA System (Werfen group, Barcelona, Spain) 
IBL International ELISA Kit (IBL, Hamburg, Germany) 
Direct Sandwich ELISA 
sICAM-1 
BEST 2000 ELISA System (Werfen group, Barcelona, Spain) 
IBL International ELISA Kit (IBL, Hamburg, Germany) 
Direct Sandwich ELISA 
sVCAM-1 
BEST 2000 ELISA System (Werfen group, Barcelona, Spain) 
IBL International ELISA Kit (IBL, Hamburg, Germany) 
Indirect Sandwich ELISA 
MMP-9 
BEST 2000 ELISA System (Werfen group, Barcelona, Spain) 
IBL International ELISA Kit (IBL, Hamburg, Germany) 
Indirect Sandwich ELISA 
hsCRP BN II System (Siemens®, Marburg, Germany) Nephelometry 
IL-6 
BEST 2000 ELISA System (Werfen group, Barcelona, Spain) 
IBL International ELISA Kit (IBL, Hamburg, Germany) 
Indirect Sandwich ELISA 
 
c) Statistical Analysis 
We performed statistical analyses using version 
5.0 of the Graph Pad Prism software (Graph Pad 
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The study included 31 children with type 1 
diabetes mellitus, from 6 to 12 years old (mean age: 
8.36±1.8 years), and 58 age- and sex-matched healthy 
children, also between the ages of 6 and 12 (mean age: 
6.9±1.7 years), designated as the control group. 
Children with T1DM were treated at the Pediatric 
Endocrinology Outpatient Clinic at the Brasilia University 
Hospital and at the Pediatric Clinic of the Brasilia 
Children´s Hospital. The children in the control group 
were recruited among relatives of hospital staff involved 
in the study.
All children with T1DM included in the study 
underwent detailed physical examinations (which 
included blood pressure and skin sensitivity monitoring), 
biochemical blood and urine tests (including complete
evaluation of renal function and microalbuminuria), 
and complete ophthalmic examination, all under the 
supervision of a pediatric endocrinologist. Children in 
the control group had normal height and weight for   
their age, according to the Center for Disease Control 
and Prevention’s (CDC) guidelines [21](adapted to 
Brazilian children) [22]. They all had fasting glucose 
levels <100 mg/dL, and glycated hemoglobin (HbA1c) 
≤5.6%.
Software, San Diego, California, USA). One-way ANOVA 
and Dunnett or Bonferroni post-hoc tests were used for
comparisons between control and groups T1DM/T1DM-
 III. Results 
In a previous study by our research group [24], 
ultrasonographic techniques were used to measure the 
flow-mediated dilation (FMD) of the brachial artery and 
the thickness of the intimal and medial layers (IMT) of 
carotid arteries in order to investigate the presence of 
ED in children with T1DM. Results showing decreased 
vasodilator response, indicative of endothelial 
dysfunction, were found only in children who were 
diagnosed with T1DM at least five years prior to the 
study. These children were included in the T1DM-ED 
group of the present study, while children without ED 
were included in the T1DM group. 
To assess the presence of markers indicative of 
vascular remodeling, serum levels of the MMP-9 enzyme 
were measured in the control and the groups of children 
with diabetes. T1DM and T1DM-ED patients presented 
MMP-9 serum levels similar to the control group (control 
35.7±4 ng/mL;T1DM 35.4±2 ng/mL;T1DM-ED 36.5±1 
ng/mL), with no statistical differences between them 
(Fig. 1A). 
 
Fig. 1: Serum levels of each biomarker (1A) MMP-9 and (2A) sICAM showed no statistical differences between 
control and diabetic groups. (1C) E-selectin was significantly higher in T1DM-ED (*p = 0.001) than in the control 
(Dunnett’s post-hoc test) and in T1DM (#p = 0.001):  (1D) sVCAM was elevated (* and **p = 0.0001) in both 
groups of diabetic patients, with and without ED. Results were analyzed using one-way ANOVA and Dunnett’s post-
hoc test. 
Serum levels of E-selectin, sVCAM-1, and 
sICAM-1 were also investigated.  Patients with diabetes 
had similar sICAM-1 levels to subjects in the control 
group, with no statistical differences between control 
(398.1±81 ng/mL), T1DM (394.1±56ng/mL), or T1DM-
ED (416.2±44ng/mL) (Fig. 1B). 
Significantly higher levels of E-selectin (p = 
0.001) were found in T1DM-ED (331.2±77 ng/mL) when 
compared to the control (222.2±74 ng/mL), whereas 
levels in T1DM (244.4±81ng/mL) did not differ 
significantly from the control (Fig. 1C). In contrast, 
increased levels of sVCAM-1 (p = 0.0001) were found in 
both DM groups (T1DM 1,359.1±273 ng/mL; T1DM-ED 
1,358.2±112 ng/mL)in comparison to the control 
(828.5±212 ng/mL) (Fig. 1D).  
Serum levels of IL-6 and hsCRP were measured 
to verify the presence of an inflammatory state in 
individuals with diabetes. Serum levels of IL-6 were 
within reference values and presented no statistically 
significant differences between control (0.99±0.5 
ng/mL), T1DM (1.13±0.6 ng/mL), and T1DM-ED 
(0.83±0.2 ng/mL) (Fig.2A). 
However, elevated hsCRP levels were observed 
in DM groups. The values were 0.15±0.1 mg/L for the 
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ED and between T1DM and T1DM-ED, respectively. 
Differences were considered statistically significant 
when p ≤ 0.05.
control, 0.19±0.2 mg/L for T1DM, and 0.36±0.2 mg/L 
for T1DM-ED. Values were significantly higher (p = 
0.002) in the T1DM-ED group than in the control group 
(Fig. 2B). This result indicates the presence of an 
inflammatory state in children with endothelial 
dysfunction. 
 
Fig. 2: IL-6 (A) and hs-CRP levels (B) in control and diabetic groups Results were analyzed using one-way ANOVA 
and Dunnett’s post-hoc test, comparing control and T1DM-ED for hs-CRP (*p = 0.0026). 
IV. Discussion 
Diabetes mellitus is one of the most prevalent 
chronic diseases affecting children and adolescents. 
The World Health Organization (WHO) estimates that 
diabetes will represent the seventh leading cause         
of death worldwide by 2030 [25]. Vascular alterations 
are the main cause of morbidity and mortality in patients 
with Type 1 diabetes mellitus, including children and 
adolescents [26, 27]. Endothelial dysfunction has    
been shown to precede vascular alterations and can   
be used as an early predictor of cardiovascular diseases 
[28].Endothelial cells actively regulate vascular tonus 
and reactivity under physiological and pathological 
conditions, responding to mechanical stimuli and 
neurohumoral mediators with the release of a variety of 
vascular relaxing/constricting factors and synthesizing 
substances that regulate inflammation and 
homeostasis. As the actions of endothelial cells        
may affect several systems, either simultaneously         
or sequentially, a gold standard test for evaluation        
of endothelial dysfunction has not yet been established 
[29].Endothelial function is usually estimated by 
variations in blood flow or arterial vessel diameter          
in response to mechanical or chemical stimuli, 
evaluated invasively, through coronary catheterization, 
or non-invasively, through ultrasound examinations, 
such as measurement of FMD of the brachial artery and 
IMT of carotid arteries [29].Despite being non-invasive, 
these tests require time, equipment, and skilled 
personnel, not always readily available in health 
services. On the other hand, laboratory tests based on 
blood samples are usually faster and cheaper and could 
serve as tools for the early prevention of cardiovascular 
complications. Among the various molecules known to 
participate in ED, hsCRP, IL-6, sICAM-1, sVCAM-1, E-
selectin, and MMP-9 were investigated as potential 
biomarkers in children with Type 1 diabetes mellitus in 
this study. 
The majority of the data available on markers of 
endothelial dysfunction come from studies in adult 
patients with Type 2 diabetes mellitus (T2DM). 
Furthermore, most of theT1DM data available have been 
obtained from adult patients and/or patients who 
already showed vascular complications [9,30]. Data on 
T1DM patients, especially children, are still scarce. The 
present study evaluated children with T1DM with and 
without ED who did not present vascular diseases and 
healthy children as control. 
 
 
 
 
 
 
However, serum levels of MMP-9 do not seem 
to be an indicator of the endothelial dysfunction that 
precedes vascular complications. Lee et al [35] reported 
no increase in MMP-9 levels in the serum of T2DM 
adults diagnosed up to 3 years prior to the study and no 
complications. Our results indicate that, even in children 
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Monitoring MMP-9 levels appears to be useful 
to predict microvascular complications in T1DM. The 
hyperglycemic medium induces an increase in its levels 
[31], which are in accordance with the progression of 
diabetes and the severity of complications [32]. In 
children with T1DM (5 to15 years old) a substantial 
increase in MMP-9 levels in lacrimal samples was
associated with progression of diabetic retinopathy as 
well as localized pathological remodeling [33]. In
subjects with T1DM (4 to 40 years old) with sub-optimal 
glycemic control (HbA1c 8.3% ± 1.8),the level of this 
marker was notably high in urine samples and 
correlated positively with HbA1c levels and disease 
duration, suggesting that its levels may function as a 
marker of latent nephropathy, prior to clinically defined 
microalbuminuria [34].
with T1DM and more than five years of disease duration, 
there was no change in MMP-9 levels when vascular 
complications were not present since serum levels of 
MMP-9 were similar in children with and without ED. 
Atherosclerosis is considered an inflammatory 
disease, because a low-grade inflammatory state 
contributes to all stages of its development, starting with 
endothelial dysfunction, up to plaque formation and 
rupture and the thrombotic complications that follow 
[28].Cell adhesion molecules mediate the migration of 
large numbers of leukocytes (selectins) and their 
adhesion to the endothelium (VCAM-1 and ICAM-1). 
These molecules are involved in establishing an 
inflammatory process and can be useful as markers of 
inflammation [36].  
There are, however, inconsistencies in the 
results of studies with these markers, especially 
regarding ICAM and VCAM. Some studies found no 
correlation between ICAM and arterial stiffness or 
atherosclerosis [37] while others implicated only VCAM-
1 [38] or only ICAM-1 [39]. In the present study, we did 
not find significant differences between sICAM-1 levels 
in T1DM children with and without ED and the control 
group. In contrast, sVCAM-1 levels were elevated in all 
children with diabetes when compared to the control, 
and, therefore, were associated with the presence of 
diabetes but not with endothelial dysfunction in our 
study population. Further studies should clarify the role 
of sICAM-1 and sVCAM-1 in ED. 
On the other hand, more consistent results have 
been reported for E-selectin, since many studies have 
associated an increase in its levels and presence of 
diabetes [40], endothelial dysfunction [41] and elevated 
diastolic blood pressure values in T1DM children, even 
in those who had been recently diagnosed [42] or had 
no vascular disease [43]. Furthermore, the value of E-
selectin concentration to evaluate the risk of 
atherosclerosis was evident by its association with 
worsening of risk factors, such as high blood pressure, 
glucose, and lipid levels [30]. 
In the present study, we demonstrated that 
elevated E-selectin values were associated with the 
presence of ED in children with Type 1 diabetes mellitus. 
The fact that E-selectin is produced exclusively by 
endothelial cells (EC) makes it an excellent marker for 
evaluating endothelial dysfunction in comparison to 
other cell adhesion molecules, such as ICAM-1 and 
VCAM-1,which are expressed both by EC and 
leukocytes [44]. 
The acute hyperglycemia and poor glycemic 
control in the initial stages of T1DM have been 
associated with increased inflammation, which persists 
for at least two hours after the correction of 
hyperglycemia [45,46].Elevated serum levels of IL-6 and 
hsCRP were related to high levels of HbA1c [45]. We 
found the highest levels of hsCRP in children that had 
shown elevated levels of HbA1c in a previous study (p = 
0.018) [24] corroborating the association between 
hyperglycemia and inflammation. 
Although serum levels of IL-6 and hsCRP have 
been used to infer subsequent development of 
atherosclerosis [47], the most promising marker of 
inflammation for clinical application appears to be hsCRP 
[48]because, in comparison with IL-6, it has a longer half-
life, more stable serum levels, and no circadian variation 
[49]. The isolated change in hsCRP levels observed in the 
present study, with no alteration in IL-6 levels, may be due 
to the greater stability of the marker or the low-grade 
inflammation that occurs in stages preceding vascular 
damage. Nonetheless, the results confirm the utility of 
hsCRP as an early marker of ED. 
V. Conclusions 
The results reported herein suggest that hsCRP 
and E-selectin may be good markers of ED in pediatric 
patients. Currently, these markers are not routinely 
analyzed in laboratory tests, at least in Brazil [50].  Their 
inclusion in routine tests as indicators of ED could serve 
as a subsidy for early interventions for the prevention of 
vascular diseases. However, this study presents some 
limitations due to the small number of participants and 
lack of patient follow-up. Further studies are required to 
broaden the results presented herein. 
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